AMAG Pharmaceuticals (NASDAQ:AMAG) reported 12/31/2018 earnings this Morning, coming in at ($0.58) per share, beating Wall Street’s estimates of ($0.98) per Share. Revenue for the quarter came in at $88.10 million missing the streets estimates of $95.21 million

Recent Trading for AMAG Pharmaceuticals (NASDAQ:AMAG)
Shares of AMAG Pharmaceuticals closed the previous trading session at with 16.23 shares trading hands.